Neuropace
NPCE
NPCE
112 hedge funds and large institutions have $348M invested in Neuropace in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $406M → $348M (-$58.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $147K
Holders
112
Holding in Top 10
–
Calls
–
Puts
$147K
Top Buyers
| 1 | +$16.7M | |
| 2 | +$6.29M | |
| 3 | +$3.44M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.91M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$1.58M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$4.56M | |
| 3 | -$3.53M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.19M |
| 5 |
AC
Armistice Capital
New York
|
-$1.5M |
